Merck (MRK) Cash from Operations Growth (1y) (2010 - 2026)
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Cash from Ops. Growth (1y) (Qtr) |
| 1 |
Novartis Ag |
107,124,802.25 Bn |
107,124,802.25 Bn |
- |
- |
| 2 |
Eli Lilly |
969.00 Bn |
963.72 Bn |
16.22 Bn |
220.11% |
| 3 |
Johnson & Johnson |
539.46 Bn |
517.41 Bn |
15.96 Bn |
-39.77% |
| 4 |
AbbVie |
376.92 Bn |
367.57 Bn |
10.78 Bn |
134.19% |
| 5 |
Merck |
285.00 Bn |
279.35 Bn |
12.09 Bn |
56.72% |
| 6 |
Amgen |
177.58 Bn |
165.55 Bn |
5.87 Bn |
57.37% |
| 7 |
Gilead Sciences |
163.22 Bn |
155.50 Bn |
5.52 Bn |
44.79% |
| 8 |
Pfizer |
145.86 Bn |
133.09 Bn |
-1.21 Bn |
11.99% |
| 9 |
Bristol Myers Squibb |
111.90 Bn |
101.44 Bn |
8.07 Bn |
-43.50% |
| 10 |
Gsk |
88.34 Bn |
83.66 Bn |
- |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
56.72% |
| Dec 31, 2025 |
-17.19% |
| Sep 30, 2025 |
-15.81% |
| Jun 30, 2025 |
-41.58% |
| Mar 31, 2025 |
-19.09% |
| Dec 31, 2024 |
1,302.44% |
| Sep 30, 2024 |
20.40% |
| Jun 30, 2024 |
52.19% |
| Mar 31, 2024 |
130.77% |
| Dec 31, 2023 |
-94.45% |
| Sep 30, 2023 |
37.75% |
| Jun 30, 2023 |
-13.90% |
| Mar 31, 2023 |
-71.88% |
| Dec 31, 2022 |
-13.05% |
| Sep 30, 2022 |
16.78% |
| Jun 30, 2022 |
116.18% |
| Mar 31, 2022 |
283.95% |
| Dec 31, 2021 |
49.41% |
| Sep 30, 2021 |
203.22% |
| Jun 30, 2021 |
3.75% |
| Mar 31, 2021 |
75.39% |
| Dec 31, 2020 |
1,332.77% |
| Sep 30, 2020 |
-62.57% |
| Jun 30, 2020 |
-37.81% |
| Mar 31, 2020 |
-47.08% |
| Dec 31, 2019 |
-93.37% |
| Sep 30, 2019 |
51.31% |
| Jun 30, 2019 |
-8.81% |
| Mar 31, 2019 |
15.67% |
| Dec 31, 2018 |
-10.62% |
| Sep 30, 2018 |
338.51% |
| Jun 30, 2018 |
1.96% |
| Mar 31, 2018 |
303.85% |
| Dec 31, 2017 |
10.66% |
| Sep 30, 2017 |
-139.41% |
| Jun 30, 2017 |
107.31% |
| Mar 31, 2017 |
-86.84% |
| Dec 31, 2016 |
-14.46% |
| Sep 30, 2016 |
-10.27% |
| Jun 30, 2016 |
-40.67% |
| Mar 31, 2016 |
-4.86% |
| Dec 31, 2015 |
510.24% |
| Sep 30, 2015 |
-23.85% |
| Jun 30, 2015 |
16.50% |
| Mar 31, 2015 |
-3.26% |
| Dec 31, 2014 |
-134.20% |
| Sep 30, 2014 |
10.10% |
| Jun 30, 2014 |
-0.98% |
| Mar 31, 2014 |
0.85% |
| Dec 31, 2013 |
67.27% |
| Sep 30, 2013 |
25.80% |
| Jun 30, 2013 |
-19.93% |
| Mar 31, 2013 |
8.68% |
| Dec 31, 2012 |
-44.05% |
| Sep 30, 2012 |
-31.42% |
| Jun 30, 2012 |
2.38% |
| Mar 31, 2012 |
25.16% |
| Dec 31, 2011 |
-8.65% |
| Sep 30, 2011 |
76.58% |
| Jun 30, 2011 |
-14.23% |
| Mar 31, 2011 |
25.99% |
| Dec 31, 2010 |
57.81% |
| Sep 30, 2010 |
930.50% |
| Jun 30, 2010 |
343.93% |
| Mar 31, 2010 |
91.69% |
